10QSB: Optional form for quarterly and transition reports of small business issuers
Published on August 14, 2007
U.S.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
10-QSB
(Mark
One)
þ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF
1934
|
For
the quarterly period ended June 30, 2007
¨ |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934.
|
For
the transition period from ____ to____
Commission
File Number: 000-51578
CryoPort,
Inc.
(Exact
name of small business issuer as specified in its charter)
Nevada
|
88-0313393
|
(State
or other jurisdiction of
incorporation
or organization)
|
(IRS
Employer
Identification
No.)
|
451
Atlas Street Brea, California, 92821
|
||
(Address
of principal executive offices)
|
(714)
256-6100
|
||
(Issuer’s
telephone number)
|
Not
Applicable
|
||
(Former
name, former address and former fiscal year, if changed since last
report)
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes
o
No
þ
Check
whether the issuer (1) filed all reports required to be filed by Section
13 or
15(d) of the Exchange Act of 1934 during the past 12 month (or for such
shorter
period that the registrant was required to file such reports), and (2)
has been
subject to such filing requirements for the past 90 days.
Yes
þ
No
o
As
of
August 10, 2007 the Company had 39,785,061 shares of its $.001 par value
common
stock issued and outstanding.
TABLE
OF CONTENTS
Page
|
|
PART
I. FINANCIAL INFORMATION
|
2
|
ITEM
1. FINANCIAL STATEMENTS
|
2
|
BALANCE
SHEET AT JUNE 30, 2007 (unaudited)
|
2
|
UNAUDITED
STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE
30, 2007 AND 2006
|
3
|
UNAUDITED
STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED JUNE
30, 2007 AND 2006
|
4
|
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
|
5
|
ITEM
2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF
OPERATION
|
23
|
ITEM
3: CONTROLS AND PROCEDURES
|
32
|
PART
II OTHER INFORMATION
|
33
|
ITEM
1. LEGAL PROCEEDINGS
|
33
|
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
|
33
|
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
|
34
|
ITEM
4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
34
|
ITEM
5. OTHER INFORMATION
|
34
|
ITEM
6. EXHIBITS
|
35
|
SIGNATURES
|
36
|
PART
Page
1
PART
I - FINANCIAL INFORMATION
ITEM
1. FINANCIAL STATEMENTS
CRYOPORT,
INC.
CONSOLIDATED
BALANCE SHEET
June
30, 2007
|
||||
(Unaudited)
|
||||
ASSETS
|
||||
Current
assets:
|
||||
Cash
|
$
|
578,549
|
||
Accounts
receivable, net
|
2,336
|
|||
Inventories
|
147,398
|
|||
Prepaid
expenses and other current assets
|
15,320
|
|||
Total
current assets
|
743,603
|
|||
Fixed
assets, net
|
35,449
|
|||
Intangible
assets, net
|
3,529
|
|||
$
|
782,580
|
|||
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
||||
Current
liabilities:
|
||||
Accounts
payable
|
$
|
292,988
|
||
Accrued
expenses
|
104,130
|
|||
Accrued
warranty costs
|
55,782
|
|||
Accrued
salaries and related
|
155,387
|
|||
Convertible
notes payable and accrued interest
|
23,063
|
|||
Current
portion of related party notes payable
|
135,000
|
|||
Current
portion of note payable to officer
|
54,000
|
|||
Current
portion of note payable
|
24,000
|
|||
Total
current liabilities
|
844,350
|
|||
Related
party notes payable and accrued interest payable,
|
||||
net
of current portion
|
1,613,860
|
|||
Note
payable to officer, net of current portion
|
179,950
|
|||
Note
payable, net of current portion
|
35,440
|
|||
Total
liabilities
|
2,673,600
|
|||
Commitments
and contingencies
|
||||
Stockholders’
deficit:
|
||||
Common
stock, $0.001 par value; 100,000,000 shares authorized; 39,436,980
shares issued and outstanding
|
39,387
|
|||
Additional
paid-in capital
|
8,180,251
|
|||
Accumulated
deficit
|
(10,110,658
|
)
|
||
Total
stockholders’ deficit
|
(1,891,020
|
)
|
||
$
|
782,580
|
|||
See
accompanying notes to unaudited consolidated financial
statements
|
Page
2
CRYOPORT,
INC.
CONSOLIDATED
STATEMENTS OF OPERATIONS
For
The Three Months Ended June
30,
|
|||||||
2007
|
|
2006
|
|
||||
|
|
(Unaudited)
|
|
(Unaudited)
|
|||
Net
sales
|
$
|
5,541
|
$
|
18,462
|
|||
Cost
of sales
|
68,307
|
39,340
|
|||||
Gross
loss
|
(62,766
|
)
|
(20,878
|
)
|
|||
Operating
expenses:
|
|||||||
Selling,
general and administrative expenses
|
594,555
|
203,307
|
|||||
Research
and development expenses
|
28,587
|
19,109
|
|||||
Total
operating expenses
|
623,142
|
222,417
|
|||||
Loss
from operations
|
(685,908
|
)
|
(243,295
|
)
|
|||
Interest
expense
|
(58,000
|
)
|
(26,276
|
)
|
|||
Loss
before income taxes
|
(743,908
|
)
|
(269,571
|
)
|
|||
Income
taxes
|
1,600
|
-
|
|||||
Net
loss
|
$
|
(745,508
|
)
|
$
|
(269,571
|
)
|
|
Net
loss available to common stockholders per common
share:
|
|||||||
Basic
and diluted loss per common share
|
$
|
(0.02
|
)
|
$
|
(0.01
|
)
|
|
Basic
and diluted weighted average common
|
|||||||
shares
outstanding
|
37,890,100
|
30,090,329
|
See
accompanying notes to unaudited consolidated financial
statements
Page
3
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
For
The Three Months Ended
|
|||||||
June
30,
|
|||||||
2007
|
|
2006
|
|
||||
|
|
(Unaudited)
|
|
(Unaudited)
|
|||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(745,508
|
)
|
$
|
(269,571
|
)
|
|
Adjustments
to reconcile net loss to net cash
|
|||||||
used
in operating activities:
|
|||||||
Depreciation
and amortization
|
6,923
|
10,262
|
|||||
Amortization
of deferred financing costs
|
4,699
|
-
|
|||||
Amortization
of debt discount
|
29,638
|
-
|
|||||
Stock
issued to consultants
|
382,500
|
-
|
|||||
Estimated
fair value of stock options issued to
|
|||||||
consultants,
employees and directors
|
-
|
35,288
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
7,838
|
13,500
|
|||||
Inventories
|
(1,390
|
)
|
11,878
|
||||
Prepaid
expenses and other current assets
|
-
|
(4,499
|
)
|
||||
Accounts
payable
|
(13,694
|
)
|
52,802
|
||||
Accrued
expenses
|
6,903
|
(6,779
|
)
|
||||
Accrued
warranty costs
|
375
|
(1,357
|
)
|
||||
Accrued
salaries and related
|
(14,150
|
)
|
33,475
|
||||
Accrued
interest
|
22,688
|
26,276
|
|||||
Net
cash used in operating activities
|
(313,178
|
)
|
(98,725
|
)
|
|||
Cash
flows used in investing activities:
|
|||||||
Purchases
of fixed assets
|
(2,805
|
)
|
-
|
||||
Cash
flows from financing activities:
|
|||||||
Proceeds
from borrowings under notes payable
|
-
|
80,000
|
|||||
Repayment
of notes payable
|
(15,000
|
)
|
-
|
||||
Repayment
of note payable to officer
|
(9,000
|
)
|
-
|
||||
Proceeds
from issuance of common stock, net
|
554,140
|
24,685
|
|||||
Proceeds
from exercise of warrants
|
100,000
|
-
|
|||||
Net
cash provided by financing activities
|
630,140
|
104,685
|
|||||
Net
change in cash
|
314,157
|
5,960
|
|||||
Cash,
beginning of period
|
264,392
|
4,723
|
|||||
Cash,
end of period
|
$
|
578,549
|
$
|
10,683
|
|||
Supplemental
disclosure of cash flow information:
|
|||||||
Cash
paid during the period for:
|
|||||||
Interest
|
$
|
-
|
$
|
-
|
|||
Income
taxes
|
$
|
1,600
|
$
|
-
|
|||
Supplemental
disclosure of non-cash activities:
|
|||||||
Conversion
of debt and accrued interest to
|
|||||||
common
stock
|
$
|
105,679
|
$
|
-
|
See
accompanying notes to unaudited consolidated financial
statements
Page
4
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
1 - MANAGEMENT’S REPRESENTATION
The
accompanying unaudited consolidated financial statements have been prepared
by
Cryoport, Inc. (the “Company”) in accordance with accounting principles
generally accepted in the United States of America for interim financial
information, and pursuant to the instructions to Form 10-QSB and Article 10
of
Regulation S-X promulgated by the Securities and Exchange Commission.
Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statement
presentation. However, the Company believes that the disclosures are adequate
to
make the information presented not misleading. In the opinion of management,
all
adjustments (consisting primarily of normal recurring accruals) considered
necessary for a fair presentation have been included.
Operating
results for the three months ended June 30, 2007 are not necessarily indicative
of the results that may be expected for the year ending March 31, 2008. It
is
suggested that the consolidated financial statements be read in conjunction
with
the audited consolidated financial statements and related notes thereto included
in the Company’s Form 10-KSB for the fiscal year ended March 31,
2007.
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Organization
Cryoport,
Inc. (the “Company”) was originally incorporated under the name G.T.5-Limited
(“GT5”) on May 25, 1990 as a Nevada Corporation. The Company was engaged in the
business of designing and building exotic body styles for automobiles compatible
with the vehicle’s existing chassis.
On
March
15, 2005, the Company entered into a Share Exchange Agreement (the “Agreement”)
with Cryoport Systems, Inc. (“Cryoport Systems”), a California corporation, and
its stockholders whereby the Company acquired all of the issued and outstanding
shares of Cryoport Systems in exchange for 24,108,105 shares of its common
stock
(which represented approximately 81% of the total issued and outstanding shares
of common stock following the close of the transaction). Cryoport Systems was
originally formed in 1999 as a California limited liability company and was
reorganized into a California corporation on December 11, 2000. Cryoport Systems
was founded to capitalize on servicing the transportation needs of the growing
global “biotechnology revolution.” Effective March 16, 2005, the Company changed
its name to Cryoport, Inc. The transaction was recorded as a reverse
merger.
Page
5
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
The
principal focus of the Company is to market its newly developed Cryoport
Express® One-Way Shipper System, a line of rent-and-return dry cryogenic
shippers, for the transport of biological materials. These materials include
live cell pharmaceutical products; e.g., cancer vaccines, diagnostic materials,
reproductive tissues, infectious substances and other items that require
continuous exposure to cryogenic temperature (less than -150°C).
The
Company currently manufactures a line of reusable cryogenic dry shippers. These
primarily have served as vehicles for the development of the cryogenic
technology, supporting the product development of the Cryoport Express® One-Way
Shipper System, but also are essential components of the infrastructure that
supports testing and research activities of the pharmaceutical and biotechnology
industries. The Company’s mission is to provide cost effective packaging systems
for biological materials requiring, or benefiting from, a cryogenic temperature
environment over an extended period of time.
Going
Concern
The
accompanying consolidated financial statements have been prepared in conformity
with accounting principles generally accepted in the United States of America,
which contemplate continuation of the Company as a going concern. The Company
has not generated significant revenues from operations and has no assurance
of
any future revenues. The Company incurred a net loss of $745,508 during the
three month period ended June 30, 2007 and had a cash balance of $578,549 at
June 30, 2007. In addition, at June 30, 2007, the Company’s stockholders’
deficit was $1,891,020 and the Company had negative working capital of $100,747.
These factors, among others, raise substantial doubt about the Company’s ability
to continue as a going concern.
The
Company’s management recognizes that the Company must obtain additional capital
for the eventual achievement of sustained profitable operations. Management’s
plans include obtaining additional capital through equity funding sources.
However, no assurance can be given that additional capital, if needed, will
be
available when required or upon terms acceptable to the Company or that the
Company will be successful in its efforts to negotiate an extension of its
existing debt. The accompanying consolidated financial statements do not include
any adjustments that might result from the outcome of this uncertainty. The
Company has raised funds during the three month period ended June 30, 2007
in
the amount of $554,140, net of issuance costs of $67,860.
Basis
of Presentation
The
accompanying consolidated financial statements have been prepared in accordance
with accounting principles generally accepted in the United States of America.
The acquisition of Cryoport
Systems by the Company has been accounted for as a reverse acquisition, whereby
the assets and liabilities of Cryoport Systems are reported at their historical
cost. The Company had no
assets
or operations at the date of acquisition. The reverse acquisition resulted
in a
change in reporting entity for accounting and reporting purposes. Accordingly,
the accompanying consolidated financial statements have been retroactively
restated for all periods presented to report the historical financial position,
results of operations and cash flows of Cryoport Systems. Since the Company’s
stockholders retained 5,600,000 shares of common stock in connection with the
reverse acquisition, such shares have been reflected as if they were issued
to
the Company on the date of acquisition for no consideration as part of a
corporate reorganization.
Page
6
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES, continued
Principles
of Consolidation
The
consolidated financial statements include the accounts of Cryoport, Inc. and
its
wholly owned subsidiary, Cryoport Systems, Inc. All intercompany accounts and
transactions have been eliminated.
Use
of
Estimates
The
preparation of consolidated financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts
of
assets and liabilities and disclosure of contingent assets and liabilities
at
the date of the financial statements and the reported amounts of revenues and
expenses during the reporting periods. Actual results could differ from
estimated amounts. The Company’s significant estimates include allowances for
doubtful accounts and sales returns, recoverability of long-lived assets,
allowances for inventory obsolescence, accrued warranty costs, deferred tax
assets and their accompanying valuations and product liability
reserves.
Concentrations
of Credit Risk
Cash
The
Company maintains its cash accounts in financial institutions. Accounts at
these
institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”)
up to $100,000. At June 30, 2007 the Company had $505,999 of cash balances
which
were in excess of the FDIC insurance limit. The Company performs ongoing
evaluations of these institutions to limit its concentration risk
exposure.
Page
7
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
Customers
The
Company grants credit to customers within the United States of America and
to a
limited number of international customers, and does not require collateral.
Sales to other international customers are secured by advance payments, letters
of credit, or cash against documents. The Company’s ability to collect
receivables is affected by economic fluctuations in the geographic areas and
industries served by the Company. Reserves for uncollectible amounts, totaling
approximately $4,900 as of June 30, 2007, are provided based on past experience
and a specific analysis of the accounts which management believes are
sufficient. Although the Company expects to collect amounts due, actual
collections may differ from the estimated amounts.
The
Company has foreign sales primarily in Europe, Latin America, Asia and Canada.
Foreign sales are primarily under exclusive distribution agreements with
international distributors. During the three month periods ended June 30, 2007
and 2006, the Company had foreign sales of approximately $1,431 and $9,650,
respectively, which constituted approximately 26% and 52%, respectively, of
net
sales.
The
majority of the Company’s customers are in the bio-tech, bio-pharmaceutical and
animal breeding industries. Consequently, there is a concentration of
receivables within these industries, which is subject to normal credit
risk.
Fair
Value of Financial Instruments
The
Company’s consolidated financial instruments consist of cash, accounts
receivable, related party notes payable, payables, accrued expenses, convertible
notes payable and a note payable to a third party. The carrying value for all
such instruments, except the related party notes payable, approximates fair
value at June 30, 2007. The difference between the fair value and recorded
values of the related party notes payable is not significant.
Inventories
Inventories
are stated at the lower of standard cost or current estimated market value.
Cost
is determined using the first-in, first-out method. The Company periodically
reviews its inventories and records a provision for excess and obsolete
inventories based primarily on the Company’s estimated forecast of product
demand and production requirements. Once established, write-downs of inventories
are considered permanent adjustments to the cost basis of the
obsolete or excess inventories. Work in process and finished goods include
material, labor and applied overhead. Inventories at June 30, 2007 consist
of
the following:
Raw
materials
|
$
|
63,607
|
||
Work
in process
|
47,561
|
|||
Finished
goods
|
36,230
|
|||
$
|
147,398
|
Page
8
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES, continued
Fixed
Assets
Depreciation
and amortization of fixed assets are provided using the straight-line method
over the following useful lives:
Furniture
and fixtures
|
7
years
|
|
Machinery
and equipment
|
5-7
years
|
|
Leasehold
improvements
|
Lesser
of lease term or estimated useful
life
|
Betterments,
renewals and extraordinary repairs that extend the lives of the assets are
capitalized; other repairs and maintenance charges are expensed as incurred.
The
cost and related accumulated depreciation applicable to assets retired are
removed from the accounts, and the gain or loss on disposition is recognized
in
current operations.
Intangible
Assets
Patents
and Trademarks
Patents
and trademarks are amortized, using the straight-line method, over their
estimated useful life of five years.
Long-Lived
Assets
The
Company’s management assesses the recoverability of its long-lived assets upon
the occurrence of a triggering event by determining whether the depreciation
and
amortization of long-lived assets over their remaining lives can be recovered
through projected undiscounted future cash flows. The amount of long-lived
asset
impairment, if any, is measured based on fair value and is charged to operations
in the period in which long-lived asset impairment is determined by management.
At June 30, 2007, the Company’s management believes there is no impairment of
its long-lived assets. There can be no assurance however, that market conditions
will
not
change or demand for the Company’s products will continue, which could result in
impairment of its long-lived assets in the future.
Page
9
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
Accrued
Warranty Costs
Estimated
costs of the standard warranty, included with products at no additional cost
to
the customer for a period up to one year, are recorded as accrued warranty
costs
at the time of product sale. Costs related to servicing the extended warranty
plan are expensed as incurred.
The
following represents the activity in the warranty accrual account during the
three month periods ended June 30:
2007
|
2006
|
||||||
Beginning
warranty accrual
|
$
|
55,407
|
$
|
59,532
|
|||
Increase
in accrual (charged to cost of sales)
|
375
|
1,268
|
|||||
Charges
to accrual (product replacements)
|
-
|
(2,625
|
)
|
||||
Ending
warranty accrual
|
$
|
55,782
|
$
|
58,175
|
Revenue
Recognition
Revenue
is recognized in accordance with Staff Accounting Bulletin (“SAB”) No. 101,
Revenue
Recognition in Financial Statements,
as
revised by SAB 104. The Company recognizes revenue when products are shipped
to
a customer and the risks and rewards of ownership and title have passed based
on
the terms of the sale. The Company records a provision for sales returns and
claims based upon historical experience. Actual returns and claims in any future
period may differ from the Company’s estimates.
Accounting
for Shipping and Handling Revenue, Fees and Costs
The
Company classifies amounts billed for shipping and handling as revenue in
accordance with Emerging Issues Task Force (“EITF”) Issue No. 00-10,
Accounting
for Shipping and Handling Fees and Costs.
Shipping and handling fees and costs are included in cost of sales.
Advertising
Costs
The
Company expenses the cost of advertising when incurred as a component of
selling, general and administrative expenses. During the three month periods
ended June 30, 2007 and 2006, the Company expensed approximately $1,584 and
$250, respectively, in advertising costs.
Page
10
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
Research
and Development Expenses
The
company expenses internal research and development costs as incurred. Third
party research and development costs are expensed when the contracted work
has
been performed.
Stock-Based
Compensation
Adoption
of SFAS 123(R)
The
Company accounts for equity issuances to employees and directors in accordance
to Statement of Financial Accounting Standards No. 123 (revised 2004),
Share-Based
Payment,
(“SFAS
123(R)”) which establishes standards for the accounting of transactions in which
an entity exchanges its equity instruments for goods or services, primarily
focusing on accounting for transactions where an entity obtains employee
services in share-based payment transactions. SFAS No. 123(R) requires a
public entity to measure the cost of employee services received in exchange
for
an award of equity instruments, including stock options, based on the grant-date
fair value of the award and to recognize it as compensation expense over the
period the employee is required to provide service in exchange for the award,
usually the vesting period.
SFAS
123(R) requires companies to estimate the fair value of share-based payment
awards on the date of grant using an option-pricing model. The value of the
portion of the award that is ultimately expected to vest is recognized as
expense over the requisite service periods in the Company’s consolidated
statement of operations.
Stock-based
compensation expense recognized during the period is based on the value of
the
portion of share-based payment awards that is ultimately expected to vest during
the period.
As
stock-based compensation expense recognized in the consolidated statements
of
operations for the three month periods ended June 30, 2007 and 2006 is based
on
awards ultimately expected to vest, it has been reduced for estimated
forfeitures, if any. SFAS 123(R) requires forfeitures to be estimated at the
time of grant and revised, if necessary, in subsequent periods if actual
forfeitures differ from those estimates. The estimated average forfeiture rate
for the three month periods ended June 30, 2007 and 2006 were zero as the
Company has not had a significant history of forfeitures and does not expect
forfeitures in the future. There were no warrants or stock options granted
to
employees and directors during the three month periods ended June 30, 2007
and
2006.
Page
11
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
Plan
Description
The
Company’s stock option plan provides for grants of incentive stock options and
nonqualified options to employees, directors and consultants of the Company
to
purchase the Company’s shares at the fair value, as determined by management and
the board of directors, of such shares on the grant date. The options generally
vest over a five-year period beginning on the grant date and have a ten-year
term. As of June 30, 2007, the Company is authorized to issue up to 5,000,000
shares under this plan and has 2,511,387 shares available for future
issuances.
Summary
of Assumptions and Activity
The
fair
value of stock-based awards to employees and directors is calculated using
the
Black-Scholes option pricing model, even though this model was developed to
estimate the fair value of freely tradable, fully transferable options without
vesting restrictions, which differ significantly from
the
Company’s stock options. The Black-Scholes model also requires subjective
assumptions, including future stock price volatility and expected time to
exercise, which greatly affect the calculated values. The expected term of
options granted is derived from historical data on
employee exercises and post-vesting employment termination behavior. The
risk-free rate selected to value any particular grant is based on the U.S
Treasury rate that corresponds to the pricing
term of the grant effective as of the date of the grant. The expected volatility
is based on the historical volatility of the Company’s stock price. These
factors could change in the future, affecting the determination of stock-based
compensation expense in future periods.
June
30,
|
June
30,
|
|||
2007
|
2006
|
|||
Stock
options and warrants:
|
||||
Expected
term
|
N/A
|
N/A
|
||
Expected
volatility
|
N/A
|
N/A
|
||
Risk-free
interest rate
|
N/A
|
N/A
|
||
Expected
dividends
|
N/A
|
N/A
|
A
summary
of employee and director options and warrant activity for the three month period
ended June 30, 2007 is presented below:
Shares
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Contractual Term (Yrs.)
|
Aggregate
Intrinsic Value
|
||||||||||
Outstanding
at March
31, 2007
|
3,747,563
|
$
|
0.59
|
7.46
|
|||||||||
Granted
|
-
|
$
|
-
|
|
|||||||||
Exercised
|
-
|
$
|
-
|
||||||||||
Forfeited
|
-
|
$
|
-
|
||||||||||
Outstanding
and exercisable
at
June 30, 2007
|
3,747,563
|
$
|
0.59
|
7.21
|
$
|
4,260,947
|
Page
12
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
There
were no warrants or stock options granted to employees and directors during
the
three months ended June 30, 2007 and 2006. There were no vesting of prior
warrants or stock options issued during the three months ended June 30, 2007.
During the three months ended June 30, 2006, in connection with the vesting
of
prior options issued, the Company recorded total charges of $35,288 in
accordance with the provisions of SFAS 123(R), which have been included in
selling, general and administrative expenses in the accompanying consolidated
statement of operations. No employee or director warrants or stock options
expired during the three months ended June 30, 2007 and 2006. The Company issues
new shares from its authorized shares upon exercise of warrants or
options.
As
of
March 31, 2007 all previously issued stock options and warrants were fully
vested. Therefore, as of June 30, 2007 there were no unvested stock options
or
warrants
and no
unrecognized compensation cost related to employee and director stock option
compensation arrangements. The total fair value of shares vested during the
three months ended June 30, 2007 and 2006 were $0 and $35,288,
respectively.
Issuance
of Stock for Non-Cash Consideration
All
issuances of the Company's stock for non-cash consideration have been assigned
a
per share amount equaling either the market value of the shares issued or the
value of consideration received, whichever is more readily determinable. The
majority of the non-cash consideration received pertains to services rendered
by
consultants and others and has been valued at the market value of the shares
on
the dates issued. In certain instances, the Company has discounted the values
assigned to the issued shares for illiquidity and/or restrictions on
resale.
Page
13
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
The
Company's accounting policy for equity instruments issued to consultants and
vendors in exchange for goods and services follows the provisions of EITF 96-18,
Accounting
for Equity Instruments That are Issued to Other Than Employees for Acquiring,
or
in Conjunction with Selling, Goods or Services
and EITF
00-18, Accounting
Recognition for Certain Transactions Involving Equity Instruments Granted to
Other Than Employees.
The
measurement date for the fair value of the equity instruments issued is
determined at the earlier of (i) the date at which a commitment for performance
by the consultant or vendor is reached or (ii) the date at which the consultant
or vendor's performance is complete. In the case of equity instruments issued
to
consultants, the fair value of the equity instrument is recognized over the
term
of the consulting agreement. In accordance with EITF 00-18, an asset acquired
in
exchange for the issuance of fully vested, nonforfeitable equity instruments
should not be presented or classified as an offset to equity on the grantor's
balance sheet once the equity instrument is granted for accounting purposes.
Accordingly, the Company records the fair value of fully vested non-forfeitable
common stock issued for future consulting services as prepaid services in its
consolidated balance sheet.
Income
Taxes
The
Company accounts for income taxes in accordance with SFAS No. 109, Accounting
for Income Taxes.
Under
the asset and liability method of SFAS 109, deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in
the
years in which those temporary differences are expected to be recovered or
settled. Under SFAS No. 109, the effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that includes
the
enactment date. A valuation allowance is provided for certain deferred tax
assets if it is more likely than not that the Company will not realize tax
assets through future operations. The Company is a subchapter "C" corporation
and files a federal income tax return. The Company files separate state income
tax returns for California and Nevada.
Basic
and Diluted Loss Per Share
The
Company has adopted SFAS No. 128, Earnings
Per Share
(see
Note 6).
Basic
loss per common share is computed based on the weighted average number of shares
outstanding during the period. Diluted loss per share is computed by dividing
net loss by the weighted average shares outstanding assuming all dilutive
potential common shares were issued. Basic and diluted loss per share are the
same as the effect of stock options and warrants on loss per share are
anti-dilutive and thus not included in the diluted loss per share calculation.
The impact under the treasury stock method of dilutive stock options and
warrants and the if-converted method of convertible debt would have resulted
in
an increase of 3,868,953 and 692,957 shares for the periods ended June 30,
2007
and 2006, respectively.
Page
14
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES, continued
Convertible
Debentures
If
the
conversion feature of conventional convertible debt provides for a rate of
conversion that is below market value, this feature is characterized as a
beneficial conversion feature (“BCF”). A BCF is recorded by the Company as a
debt discount pursuant to EITF Issue No. 98-5, Accounting
for Convertible Securities with Beneficial Conversion Features or Contingency
Adjustable Conversion Ratio
(“EITF
98-05”), and EITF Issue No. 00-27, Application
of EITF Issue No. 98-5 to Certain Convertible Instruments (“EITF
00-27”). In those circumstances, the convertible debt will be recorded net of
the discount related to the BCF. The Company amortizes the discount to interest
expense over the life of the debt using the effective interest method (see
Note
4).
Recent
Accounting Pronouncements
The
Financial Accounting Standards Board (“FASB”) has issued FASB Statement No. 157,
Fair
Value Measurements. This
new
standard provides guidance for using fair value to measure assets and
liabilities. Under Statement 157, fair value refers to the price that would
be
received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants in the market in which the reporting
entity transacts. In this standard, the FASB clarifies the principle that fair
value should be based on the assumptions market participants would use when
pricing the asset or liability. In support of this principle, Statement 157
establishes a fair value hierarchy that prioritizes the information used to
develop those assumptions. The fair value hierarchy gives the highest priority
to quoted prices in active markets and the lowest priority to unobservable
data,
for example, the reporting entity’s own data. Under the standard, fair value
measurements would be separately disclosed by level within the fair value
hierarchy. The provisions of Statement 157 are effective for financial
statements issued for fiscal years beginning after November 15, 2007, and
interim periods within those fiscal years. Earlier application is encouraged,
provided that the reporting entity has not yet issued financial statements
for
that fiscal year, including any financial statements for an interim period
within that fiscal year. The
adoption of this pronouncement is not expected to have material effect on the
Company’s financial statements.
The
FASB
has issued FASB Staff Position (“FSP”) EITF 00-19-2, Accounting
for Registration Payment Arrangements. This
FSP
specifies that the contingent obligation to make future payments or otherwise
transfer consideration under a registration payment arrangement, whether issued
as a separate agreement or included as a provision of a financial instrument
or
other agreement, should be separately recognized and measured in accordance
with
FASB Statement No. 5, Accounting
for Contingencies. The
FSP
further clarifies that a financial instrument subject to a registration payment
arrangement should be accounted for in accordance with other applicable
GAAP without regard to the contingent obligation to transfer consideration
pursuant to the registration payment arrangement. This FSP amends various
authoritative literature notably FASB Statement No. 133, Accounting
for Derivative Instruments and Hedging Activities, FASB
Statement No. 150, Accounting
for Certain Financial Instruments with Characteristics of both Liabilities
and
Equity, and
FASB
Interpretation No. 45, Guarantor’s
Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others. This
FSP
is effective immediately for registration payment arrangements and the financial
instruments subject to those arrangements that are entered into or modified
subsequent to December 21, 2006. For registration payment arrangements and
financial instruments subject to those arrangements that were entered into
prior
to December 21, 2006, the guidance
in the FSP is effective for financial statements issued for fiscal years
beginning after December 15, 2006, and interim periods within those fiscal
years.
The
adoption of this pronouncement did not have a material effect on the Company’s
consolidated financial statements.
Page
15
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
2 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES,
continued
In
July
2006, the FASB issued FASB Interpretation No. 48, Accounting
for Uncertainty in Income Taxes, an interpretation of FASB Statement No.
109
(“FIN
48”). FIN 48 clarifies the accounting for uncertainty in income taxes by
prescribing the recognition threshold a tax position is required to meet before
being recognized in the financial statements. It also provides guidance on
derecognition, classification, interest and penalties, accounting in interim
periods, disclosure, and transition. The Company adopted FIN 48 is effective
on
April 1, 2007. The adoption of FIN 48 has not had a material impact on the
Company’s consolidated results of operations and financial
condition.
In
May 2005, the FASB issued SFAS No. 154, Accounting
Changes and Error Corrections,
a
replacement of APB Opinion No. 20, Accounting
Changes,
and
Statement No. 3, Reporting
Accounting Changes in Interim Financial Statements.
SFAS
No. 154 changes the requirements for the accounting for and reporting of a
change in accounting principle. Previously, most voluntary changes in accounting
principles were required recognition via a cumulative effect adjustment within
net income of the period of the change. SFAS No. 154 requires retrospective
application to prior periods’ financial statements, unless it is impracticable
to determine either the period-specific effects or the cumulative effect of
the
change. SFAS No. 154 is effective for accounting changes and correction of
errors made in fiscal years beginning after December 15, 2005; however,
SFAS No. 154 does not change the transition provisions of any existing
accounting pronouncements. The adoption of SFAS No. 154 did not have a
material effect on the Company’s consolidated financial position, results of
operations or cash flows.
On
February 15, 2007, the FASB issued FASB Statement No. 159, The
Fair Value Option for Financial Assets and Financial Liabilities - Including
an
Amendment of FASB Statement No. 115.
SFAS 159
permits an entity to choose to measure many financial instruments and certain
other
items at fair value. This option is available to all entities, including
not-for-profit organizations. Most of the provisions in Statement 159 are
elective; however, the amendment to FASB Statement No. 115, Accounting
for Certain Investments in Debt and Equity Securities,
applies
to all entities with available-for-sale and trading securities. Some
requirements apply differently to entities that do not report net income. The
fair value option established by Statement 159 permits all entities to choose
to
measure eligible items at fair value at specified election dates. A business
entity will report unrealized gains and losses on items for which the fair
value
option has been elected in earnings (or another performance indicator if the
business entity does not report earnings) at each subsequent reporting date.
A
not-for-profit organization will report unrealized gains and losses in its
statement of activities or similar statement. The fair value option:
(a)
may be
applied instrument by instrument, with a few exceptions, such as investments
otherwise accounted for by the equity method; (b)
is
irrevocable (unless a new election date occurs); and (c)
is
applied only to entire instruments and not to portions of instruments. Statement
159 is effective as of the beginning of an entity’s first fiscal year that
begins after November 15, 2007. Early adoption is permitted as of the
beginning of the previous fiscal year provided that the entity makes that choice
in the first 120 days of that fiscal year and also elects to apply the
provisions of FASB Statement No. 157, Fair
Value Measurements.
The
adoption of this pronouncement is not expected to have material effect on the
Company’s consolidated financial statements.
Page
16
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
3 - COMMITMENTS AND CONTINGENCIES
Litigation
The
Company becomes a party to product litigation in the normal course of business.
The Company accrues for open claims based on its historical experience and
available insurance coverage. In the opinion of management, there are no legal
matters involving the Company that would have a material adverse effect upon
the
Company’s condition or results of operations.
Indemnities
and Guarantees
The
Company has made certain indemnities and guarantees, under which it may be
required to make payments to a guaranteed or indemnified party, in relation
to
certain actions or transactions. The Company indemnifies its directors,
officers, employees and agents, as permitted under the laws of the States of
California and Nevada. In connection with its facility lease, the Company has
indemnified its lessor for certain claims arising from the use of the facility.
In connection with its business merger, the Company has indemnified the merger
candidate for certain claims arising from the failure of the Company to perform
any of its representation or obligations under the agreements. The duration
of
the guarantees and indemnities
varies, and is generally tied to the life of the agreement. These guarantees
and
indemnities
do not provide for any limitation of the maximum potential future payments
the
Company could be obligated to make. Historically, the Company has not been
obligated nor incurred any payments for these obligations and, therefore, no
liabilities have been recorded for these indemnities and guarantees in the
accompanying consolidated balance sheet.
Page
17
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
4 - NOTES PAYABLE
As
of
June 30, 2007, the Company had aggregate principal balances of $1,324,500 in
outstanding unsecured indebtedness owed to five related parties, including
four
former members of the board of directors, representing working capital advances
made to the Company from February 2001 through March 2005. These notes bear
interest at the rate of 6% per annum and provide for aggregate monthly principal
payments which began April 1, 2006 of $2,500, and which increase by an aggregate
of $2,500 every six months to a maximum of $10,000 per month. As of June 30,
2007, the aggregate principal payments totaled $5,000 and are scheduled to
increase to an aggregate of $7,500 per month beginning July 2007. Any remaining
unpaid principal and accrued interest is due at maturity on various dates
through March 1, 2015.
Related
-
party interest expense under these notes was $20,019 and $24,366 for the three
months ended June 30, 2007 and 2006, respectively. Accrued interest, which
is
included in notes payable in the accompanying consolidated balance sheet,
related to these notes amounted to $424,360 as of June 30, 2007. As
of
June 30, 2007, the Company had not made the required payments under the
related-party notes which were due on April 1, May 1, and June 1, 2007. However,
pursuant to the note agreements, the Company has a 120-day grace period to
pay
missed payments before the notes are in default. On July 31, 2007, the Company
paid the April 1 note payments due on these related party notes. Management
expects to continue to pay all payments due prior to the expiration of the
120-day grace periods.
In
October 2006, the Company entered into an Agency Agreement with a broker to
raise capital in a private placement offering of convertible debentures under
Regulation D. From February 2006 through January 2007, the Company received
a
total of $120,000 under this private placement offering of convertible debenture
debt. Related to the issuance of the convertible debentures, the Company paid
commissions to the broker totaling $15,600, which were capitalized as deferred
financing costs. During the three months ended June 30, 2007, the Company
amortized the remaining $4,699 of deferred financing costs to interest
expense.
Per
the
terms of the convertible debenture agreements, the notes have a term of 180
days
from issuance and are redeemable by the Company with two days notice. The notes
bear interest at 15% per annum and are convertible into shares of the Company’s
common stock at a ratio of 6.67 shares for every dollar of debt converted.
The
proceeds of the convertible notes have and will be used in the ongoing
operations of the Company. During the three months ended June 30, 2007
the
Company converted $98,500 of principal balances and $7,179 of accrued interest
relating to these convertible debentures into 705,366 shares of common stock
at
a conversion price of $0.15 per share. As of June 30, 2007, the remaining
balance of the convertible debenture notes and accrued interest was $23,063.
During the three months ended June 30, 2007, the Company recorded interest
expense of $2,669 related to these notes. See Note 8, Subsequent Events, for
conversion of remaining convertible debentures.
Page
18
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
4 - NOTES PAYABLE, continued
In
connection with the issuance of the convertible debt, the Company recorded
a
debt discount totaling $106,167 related to the beneficial conversion feature
of
the notes. The Company amortized the debt discount using the effective interest
method through the maturity dates of the notes. During the three months ended
June 30, 2007, the Company recorded additional interest expense of $29,638
related to the final amortization of the debt discounts.
In
August
2006, Peter Berry, the Company’s Chief Executive Officer, agreed to convert his
deferred salaries to a long-term note payable. Under the terms of this note,
monthly payments of $3,000 will be made to Mr. Berry beginning in January 2007.
In January 2008, these payments will increase to $6,000 and remain at that
amount until the loan is fully paid in December 2010. Interest of 6% per annum
on the outstanding principal balance of the note will begin to accrue on January
1, 2008 and will be paid on a monthly basis along with the monthly principal
payment beginning in January 2008. As of June 30, 2007, the total amount of
deferred salaries under this arrangement was $233,950, of which $179,950 is
recorded as a long-term liability in the accompanying consolidated balance
sheet.
The
Company has a non-interest bearing note payable to a third party for $77,304,
which was due in April 2003. The Company is currently required to make monthly
payments of $2,000 as agreed upon with the third party. As of June 30, 2007,
the
remaining unpaid balance was $59,440.
NOTE
5 - EQUITY
During
the three months ended June 30, 2007, 131,250 warrants were exercised at an
average price of $0.76 per share for cumulative proceeds of
$100,000.
In
January 2007, the Company entered into an Agency Agreement with a broker to
raise funds in a private placement offering of common stock under Regulation
D.
During the three months ended June 30, 2007, in connection with this agreement,
3,443,333 shares of the Company’s common stock were sold to investors at an
average price of $0.18 per share for proceeds of $554,140 to the Company, net
of
issuance costs of $67,860.
During
the three months ended June 30, 2007 the Company converted $98,500 of principal
balances and $7,179 of accrued interest relating to these convertible debentures
into 705,366 common stock shares at a conversion price of $0.15 per share (see
Note 4).
Page
19
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
5 - EQUITY, continued
In
April
2007, the Company issued 375,000 shares of restricted common stock in lieu
of
fees paid to a consultant. These shares were issued at a value of $1.02 per
share (based on the underlying stock price on the agreement date after a fifteen
percent deduction as the shares are restricted) for a total cost of $382,500
which has been included in selling, general and administrative expenses for
the
three months ended June 30, 2007.
In
June
2007, the Company issued a total of 6,052,000 warrants to purchase shares of
the
Company’s common stock at an average price of $0.35 per share to 68 individual
investors in connection with funds raised in private placement offerings. The
warrants have exercise periods of 18 months originating from the related
investment date. The expiration dates range from December 2007 to October
2008.
During
the three months ended June 30, 2007 and 2006, compensation expense from the
vesting of options issued to employees and non-employees totaled $0 and $35,288,
respectively, and has been included in selling, general and administrative
expenses in the accompanying consolidated statements of operations (see Note
2).
NOTE
6 - LOSS PER SHARE
The
following is a reconciliation of the numerators and denominators of the basic
and diluted loss per share computations for the three month periods ended June
30:
2007
|
|
2006
|
|||||
Numerator
for basic and diluted earnings per share:
|
|||||||
Net
loss available to common stockholders
|
$
|
(711,758
|
)
|
$
|
(269,571
|
)
|
|
Denominator
for basic and diluted loss per common share:
|
|||||||
Weighted
average common shares outstanding
|
37,890,100
|
30,090,329
|
|||||
Net
loss per common share available to common
stockholders
|
$
|
(0.02
|
)
|
$
|
(0.01
|
)
|
Page
20
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
7 - RELATED PARTY TRANSACTIONS
See
Note 4, Notes Payable, for related party debt
transactions.
In
June
2005, the Company retained the legal services of Gary C. Cannon, Attorney at
Law, for a monthly retainer fee of $6,500. At that same time, Mr. Cannon also
became the Company’s Secretary and a member of the Company’s Board of Directors.
The total amount paid to Mr. Cannon for retainer fees and out-of-pocket expenses
for the three months ended June 30, 2007 and 2006 was $19,500 and $19,500,
respectively.
NOTE
8 - SUBSEQUENT EVENTS
In
July
2007, the Company entered into an Agency Agreement with a broker to raise funds
in a private placement offering of common stock under Regulation D. As of August
10, 2007, in connection with this agreement, 168,750 shares of the Company’s
common stock were sold to investors at an average price of $0.80 per share
for
proceeds of $117,450 to the Company, net of issuance costs of
$17,550.
In
July
2007, the Company issued 154,331 shares of common stock pursuant to the terms
of
convertible debenture agreements. The Company converted $23,178 of convertible
notes with aggregate principal balances of $21,500 and accrued interest of
$1,678. The interest on the convertible notes was accrued at 15% per annum
through the conversion dates. The notes were converted into common stock at
a
ratio of 6.67 shares for every dollar of debt converted, representing
approximately $0.15 per share.
In
July
2007, the Company issued warrants to purchase a total of 699,438 shares of
the
Company’s common stock at an average exercise price of $0.29 per share to a
broker in connection with funds raised in private placement offerings.
In
August
2007, the Company issued 25,000 shares pursuant to the exercise of warrants
at
an exercise price of $0.30 per share for proceeds of $7,500 to the
Company.
Page
21
CRYOPORT,
INC.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
For
The Three Months Ended June 30, 2007 and 2006
NOTE
8 - SUBSEQUENT EVENTS, continued
On
July
2, 2007, the Company entered into a lease agreement with Viking Investors -
Barents Sea, LLC for a building with approximately 11,881 square feet of
manufacturing and office space located at 20382 Barents Sea Circle, Lake Forest,
CA, 92630. The lease agreement is for a period
of
two years with renewal options for three, one year periods, beginning September
1, 2007. The lease requires initial monthly lease payments of $1.00 per square
foot or $11,881 plus $0.23 per square foot or $2,733 per month for triple-net
overhead building costs equaling a total monthly payment of $14,614 during
the
first year of occupancy. During the second year of occupancy, monthly per square
foot lease payments increase to $1.04 or $12,356. In connection with the lease
agreement the Company issued 10,000 warrants to the lessor at an exercise price
of $1.55 per share for a period of two years. The Company expects to move all
operations to the Lake Forest facility by September 15, 2007.
Page
22
ITEM
2. MANAGEMENT’S
DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.
In
this Form 10-QSB the terms “CryoPort”, “Company” and similar terms refer to
CryoPort, Inc., and its wholly owned subsidiary CryoPort Systems,
Inc.
Safe
Harbor and Forward Looking Statements:
The
Company has made some statements in this Form 10-QSB, including some under
this
“Management’s Discussion and Analysis or Plan of Operation”, and elsewhere,
which are forward-looking statements within the definition of Section 27A
of the
Securities Act of 1933, as amended, and Section 21E of the Securities Act
of
1934, as amended. These statements may discuss the Company’s future
expectations, contain projections of its plan of operation or financial
condition or state other forward-looking information. In this Form 10-QSB,
forward looking statements are generally identified by words such as
“anticipate”, “plan”, “believe”, “expect”, “estimate”, and the like.
Forward-looking statements involve future risks and uncertainties, and there
are
factors that could cause actual results or plans to differ materially from
those
expressed or implied by the statements. The forward-looking information is
based
on various factors and is derived using numerous assumptions. A reader, whether
investing in the company’s securities or not, should not place undue reliance on
these forward-looking statements, which apply only as of the date of this
Form
10-QSB.
Important
factors that may cause actual results to differ from projections include,
but
are not limited to, the following:
· |
The
success or failure of management’s efforts to implement the Company’s plan
of operations;
|
· |
The
Company’s ability to fund its operating
expenses;
|
· |
The
Company’s ability to compete with other companies that have a similar plan
of operation;
|
· |
The
effect of changing economic conditions impacting the Company’s plan of
operation;
|
· |
The
Company’s ability to meet the other risks as may be described in its
future filings with the Securities and Exchange
Commission.
|
The
Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.
General
Overview
The
following discussion and analysis of the Company’s financial condition and
results of operations should be read in conjunction with the unaudited
consolidated balance sheet as of June 30, 2007 and the related consolidated
statements of operations and cash flows for each of the three months ended
June
30, 2007 and 2006, and the related notes thereto (see Item 1 Financial
Statements) as well as the audited financial statements of the Company as
of
March 31, 2007 and 2006 and for the years then ended included in the Company’s
Annual Report on Form 10-KSB for the year ended March 31, 2007.
Page
23
The
Company cautions readers that important facts and factors described in this
Management’s Discussion and Analysis or Plan of Operation and elsewhere in this
document sometimes have affected, and in the future could affect, the Company’s
actual results, and could cause the Company’s actual results during fiscal year
2008 and beyond to differ materially from those expressed in any forward-looking
statements made by, or on behalf of the Company.
Going
Concern
As
reported in the Report of Independent Registered Public Accounting Firm on
the
Company’s March 31, 2007 and 2006 financial statements, the Company has incurred
recurring losses from operations and has a stockholders’ deficit. These factors,
among others, raise substantial doubt about the Company’s ability to continue as
a going concern.
There
are
significant uncertainties which negatively affect the Company’s operations.
These are principally related to (i) the limited distribution network for
the
Company’s reusable product line, (ii) the early stage development of the
Company’s one-way product, (iii) the absence of any commitment or firm orders
from key customers in the Company’s target markets for the reusable or the
one-way shippers, (iv) the success in bringing products concurrently under
development to market with the Company’s key customers. Moreover, there is no
assurance as to when, if ever, the Company will be able to conduct the Company’s
operations on a profitable basis. The Company’s limited sales to date for the
Company’s reusable product, the lack of any purchase requirements in the
existing distribution agreements and those currently under negotiations,
make it
impossible to identify any trends in the Company’s business prospects. There is
no assurance the Company will be able to generate sufficient revenues or
sell
any equity securities to generate sufficient funds when needed, or whether
such
funds, if available, will be obtained on terms satisfactory to the
Company.
The
Company has not generated significant revenues from operations and has no
assurance of any future significant revenues. The Company incurred net losses
of
$745,508 and $269,571 for the three month periods ended June 30, 2007 and
2006.
In addition, at June 30, 2007 the Company’s total stockholders’ deficit was
$1,891,020 and the Company had negative working capital of $100,747. The
Company
has raised funds during the three month period ended June 30, 2007 in the
amount
of $554,140, net of issuance costs of $67,860. The Company’s management
recognizes that the Company must obtain additional capital for the further
development and launch of the one-way product and the eventual achievement
of
sustained profitable operations.
The
Company anticipates that unless it are able to raise or generate proceeds
of at
least $3,000,000 within the next two to four months, although
operations will continue, the Company will be unable to fully execute its
business plan, which will result in the inability of the Company to grow
at the
desired rate. Should this situation occur, management is committed to operating
on a smaller scale until generated revenues or future funding can support
expansion.
In
order
to continue as a going concern, the Company’s management has begun taking the
following steps:
1) |
Continuing
to aggressively pursue alternative sources for significant long-term
funding of approximately $3,000,000 to $5,000,000 to support the
launch of
the Cryoport Express® One-Way Shipper
System.
|
Page
24
2) |
Continuing
to raise additional capital through a private placement offering,
initiated in July 2007, of common stock under Regulation D. Management
anticipates that the proceeds from this offering will provide
over six to nine months of additional operating
capital.
|
3) |
Continuing
to maintain minimal operating expenditures through stringent cost
containment measures. The Company’s largest expense for the three months
ended June 30, 2007 relates to consultant fees of $382,500 which
were paid
with 375,000 common stock shares in lieu of cash for consulting
services
relating to achieving financing arrangements for the Company, and
approximately $40,000 for the audit fees related to the filing
of the
Company’s annual 10-KSB report. The remaining operating expenses for the
three months ended June 30, 2007 of $201,075 related primarily
to minimal
personnel costs, rent and utilities and meeting the legal and reporting
requirements of a public company.
|
4) |
Utilizing
part-time consultants and asking employees to manage multiple roles
and
responsibilities whenever possible to keep operating costs
low.
|
5) |
Continuing
to require that key employees and the Company’s Board of Directors receive
Company stock in lieu of cash as all or part of their compensation
in an
effort to minimize monthly cash flow. With this strategy, the Company
has
established a critical mass of experienced business professionals
capable
of taking the Company forward.
|
6) |
Maintaining
current levels for sales, marketing, engineering, scientific and
operating
personnel and cautiously and gradually adding critical and key
personnel
only as necessary to help expand the Company’s product offerings in the
reusable and one-way cryogenic shipping markets, leading it to
additional
revenues and profits.
|
7) |
Adding
other expenses such as customer service, administrative and operations
staff only commensurate with producing increased
revenues.
|
8) |
Focusing
current research and development efforts only on final development,
production and distribution of the Cryoport Express® One-Way Shipper
System.
|
9) |
Continuing
to focus marketing and sales research into the bio-pharmaceutical,
clinical trials and cold-chain distribution industries in order
to better
position the Company for an immediate and successful launch of
the
Cryoport Express® One-Way Shipper System once the Company is able to
obtain adequate financing sources to support the product
launch.
|
Research
and Development
The
Company has substantially completed the research and development efforts
associated with its new product line, the Cryoport Express® One-Way Shipper
System, a line of rent-and-return dry cryogenic shippers, for the transport
of
biological materials. The Company continues to provide ongoing research
associated with the Cryoport Express® One-Way Shipper System, as it develops
improvements both the manufacturing processes and product materials for the
purpose of achieving additional cost efficiencies. As with any research effort,
there is uncertainty and risk associated with whether these efforts will
produce
results in a timely manner so as to enhance the Company’s market position. For
the three months ended June 30, 2007 and 2006, research and development costs
were $28,587 and $19,109, respectively. Company sponsored research and
development costs related to future products and redesign of present products
are expensed as incurred and include such costs as salaries, and prototype
design and materials costs.
Page
25
Critical
Accounting Policies
The
Company’s consolidated financial statements have been prepared in accordance
with accounting principles generally accepted in the United States of America.
The preparation of these financial statements requires us to make estimates
and
judgments that affect the reported amounts of assets, liabilities, revenues
and
expenses, and related disclosure of contingent assets and liabilities. The
Company bases its estimates on historical experience and on various other
assumptions that are believed to be reasonable under the circumstances, the
results of which form the basis of making judgments about the carrying values
of
assets and liabilities that are not readily apparent from other sources.
Actual
results may differ from these estimates under different assumptions or
conditions, however, in the past the estimates and assumptions have been
materially accurate and have not required any significant changes. Specific
sensitivity of each of the estimates and assumptions to change based on other
outcomes that are reasonably likely to occur and would have a material effect
is
identified individually in each of the discussions of the critical accounting
policies described below. Should the Company experience significant changes
in
the estimates or assumptions which would cause a material change to the amounts
used in the preparation of the Company’s financial statements, material
quantitative information will be made available to investors as soon as it
is
reasonably available.
The
Company believes the following critical accounting policies, among others,
affect the Company’s more significant judgments and estimates used in the
preparation of the Company’s financial statements:
Allowance
for Doubtful Accounts. The
Company maintains allowances for doubtful accounts for estimated losses
resulting from the inability of the Company’s customers to make required
payments. The allowance for doubtful accounts is based on specific
identification of customer accounts and the Company’s best estimate of the
likelihood of potential loss, taking into account such factors as the financial
condition and payment history of major customers. The Company evaluates the
collectability of the Company’s receivables at least quarterly. Such costs of
allowance for doubtful accounts are subject to estimates based on the historical
actual costs of bad debt experienced, total accounts receivable amounts,
age of
accounts receivable and any knowledge of the customers’ ability or inability to
pay outstanding balances. If the financial condition of the Company’s customers
were to deteriorate, resulting in impairment of their ability to make payments,
additional allowances may be required. The differences could be material
and
could significantly impact cash flows from operating activities.
Inventory.
The
Company writes down its inventory for estimated obsolescence or unmarketable
inventory equal to the difference between the cost of inventory and the
estimated market value based upon assumptions about future demand, future
pricing and market conditions. Inventory reserve costs are subject to estimates
made by the Company based on historical experience, inventory quantities,
age of
inventory and any known expectations for product changes. If actual future
demands, future pricing or market conditions are less favorable than those
projected by management, additional inventory write-downs may be required
and
the differences could be material. Such differences might significantly impact
cash flows from operating activities. Once established, write-downs are
considered permanent adjustments to the cost basis of the obsolete or
unmarketable inventories.
Page
26
Impairment
of Long-Lived Assets.
The
Company assesses the recoverability of its long-lived assets by determining
whether the depreciation and amortization of long-lived assets over their
remaining lives can be recovered through projected undiscounted cash flows.
The
amount of long-lived asset impairment is measured based on fair value and
is
charged to operations in the period in which long-lived asset impairment
is
determined by management. Manufacturing fixed assets are subject to obsolescence
potential as result of changes in customer demands, manufacturing process
changes and changes in materials used. The Company is not currently aware
of any
such changes that would cause impairment to the value of its manufacturing
fixed
assets.
Accrued
Warranty Costs.
The
Company estimates the costs of the standard warranty, included with the reusable
shippers at no additional cost to the customer for a period up to one year.
These estimated costs are recorded as accrued warranty costs at the time
of
product sale. These estimated costs are subject to estimates made by the
Company
based on the historical actual warranty costs, number of products returned for
warranty repair and length of warranty coverage.
Revenue
Recognition. Product
sales revenue is recognized upon passage of title to customers, typically
upon
shipment of product. Any provision for discounts and estimated returns are
accounted for in the period the related sales are recorded. Products are
generally sold with right of warranty repair for a one year period but with
no
right of return. Estimated costs of warranty repairs are recorded as accrued
warranty costs as described above. Products shipped to customers for speculation
purposes are not considered sold and no revenue is recorded by the Company
until
sales acceptance is acknowledged by the customer.
Stock-Based
Compensation.
The
Company accounts for equity issuances to non-employees in accordance with
Statement of Financial Accounting Standards ("SFAS") No. 123, Accounting
for Stock Based Compensation,
and
Emerging Issues Task Force ("EITF") Issue No. 96-18, Accounting
for Equity Instruments that are Issued to Other Than Employees for Acquiring,
or
in Conjunction with Selling, Goods and Services.
All
transactions in which goods or services are the consideration received for
the
issuance of equity instruments are accounted for based on the fair value
of the
consideration received or the fair value of the equity instrument issued,
whichever is more reliably measurable. The measurement date used to determine
the fair value of the equity instrument issued is the earlier of the date
on
which the third-party performance is complete or the date on which it is
probable that performance will occur.
The
Company adopted SFAS No. 123(R), Share-Based
Payment,
which
requires the measurement and recognition of compensation expense for all
share-based payment awards made to employees and directors related to the
Company’s 2000 Equity Incentive Plan based on estimated fair values. The Company
adopted SFAS No. 123(R) using the modified prospective transition method,
which requires the application of the accounting standard as of April 1,
2006, the first day of our fiscal year 2007. The consolidated financial
statements as of June 30, 2007 and for the three months ended June 30, 2007
and
2006 reflect the impact of adopting SFAS No. 123(R). In accordance with the
modified prospective transition method, the consolidated financial statements
for prior periods have not been restated to reflect, and do not include,
the
impact of SFAS No. 123(R). The value of the portion of the award that is
ultimately expected to vest is recognized as expense over the requisite service
periods in our consolidated statement of operations. As stock-based compensation
expense recognized in the consolidated statement of operations for each of
the
three month periods ended June 30, 2007 and 2006 is based on awards ultimately
expected to vest, it has been reduced for estimated forfeitures. SFAS
No. 123(R) requires forfeitures to be estimated at the time of grant and
revised, if necessary, in subsequent periods if actual forfeitures differ
from
those estimates. The estimated average forfeiture rate for the each of the
three
month periods ended June 30, 2007 and 2006 was zero as the Company has not
had a
significant history of forfeitures.
Page
27
Employee
stock-based compensation expense recognized under SFAS No. 123(R) for the
three months ended June 30, 2007, and 2006 was $0 and $35,288, respectively,
as
determined by the Black-Scholes valuation model. As of June 30, 2007, the
Company had no unvested stock options or warrants and total unrecognized
compensation cost, related to unvested stock options was $0 (see Note 2 to
the Company’s consolidated financial statements for additional
information.)
Results
of Operations
Three
months ended June 30, 2007 compared to three months ended June 30,
2006:
Net
Sales. During
the three months ended June 30, 2007, the Company generated $5,541 from reusable
shipper sales compared to revenues of $18,462 in the same period of the prior
year, a decrease of $12,921 (70%). This revenue decrease is primarily as
a
result of the Company’s shift in its sales and marketing focus during the
Company’s fiscal year 2006 due to the planning of the introduction of the
one-way shipper, anticipated for release in the second quarter of the Company’s
fiscal year 2008, into the bio-pharmaceutical and bio-tech industry sectors.
This shift allowed the marketing and sales efforts to focus on research into
the
bio-pharmaceutical, clinical trials and cold-chain distribution industries
in
order to better position the Company for an immediate and successful launch
of
the Cryoport Express® One-Way Shipper System once the Company obtains adequate
financing sources to support the product launch.
Cost
of Sales. For the three month period ended June 30, 2007, cost of
sales increased $28,967 (74%) to $68,307 from $39,340 for the three month
period ended June 30, 2006 primarily as the result of increased manufacturing
overhead costs incurred as the Company added personnel and incurred additional
equipment maintenance and repair costs related to the planning and preparation
for production of the Cryoport Express® One-Way Shipper. During both periods
cost of sales exceeded sales due to plant under utilization.
Gross
Profit/Loss. Gross
loss for the three month period ended June 30, 2007 increased by $41,888
(200%)
to $62,766 compared to $20,878 for the three month period ended June 30,
2006.
The increase in the gross loss is mainly attributable to the decreased
sales as
a result of the shift in the sales and marketing efforts and to additional
cost
of sales related to increased manufacturing overhead costs
incurred.
Page
28
Selling,
General and Administrative Expenses. Selling,
general and administrative expenses increased by $391,248 (192%) to $594,555
for
the three month period ended June 30, 2007 as compared to $203,308 for the
three
month period ended June 30, 2006 due primarily to consultant fees of $382,500
relating to 375,000 common stock shares issued in lieu of cash for consulting
services relating to achieving financing arrangements for the Company, to
increased travel and related costs associated with the planning for the launch
of the Cryoport Express® One-Way Shipper, and to increased directors’ and
officers’ insurance costs.
Research
and Development Expenses. Research
and development expenses increased by $9,478 (50%) to $28,587 for the three
month period ended June 30, 2007 as compared to $19,109 for the three month
period ended June 30, 2006 related to the increased research and development
activity associated with the Cryoport Express® One-Way Shipper System, as the
company strives to develop improvements in both the manufacturing processes
and
product materials for the purpose of achieving additional product cost
efficiencies.
Interest
Expenses. Interest
expense increased $31,724 (121%) to $58,000 for the three month period ended
June 30, 2007 as compared to $26,276 for the three month period ended June
30,
2006. This increase is primarily related to the amortization of discounts
and
deferred financing fees and interest expense related to the convertible
debentures held by the Company since November 2006.
Net
Loss. As
a
result of the factors described above, the net loss for the three months
ended
June 30, 2007 increased by $475,937 (177%) to $745,508 or ($0.02) per share
compared to $269,571 or ($0.01) per share for the three months ended June
30,
2006.
Assets
and Liabilities
At
June
30, 2007, the Company had total assets of $782,580 compared to total assets
of
$483,687 at March 31, 2007, an increase of $298,893 (62%). Cash was $578,549
as
of June 30, 2007, an increase of $314,157 (119%) from $264,392 in cash on
hand
as of March 31, 2007. During the three month period ended June 30, 2007,
cash
provided by financing activities of $630,140 was offset by cash used in
operations of $313,178 and purchases of fixed assets of $2,805. As of August
10,
2007, the Company’s cash on hand was approximately $470,000.
Net
accounts receivable at June 30, 2007 was $2,336, a decrease of $7,836 (77%)
from
$10,172 at March 31, 2007. This decrease is primarily due to the decreased
sales
during the three months ended June 30, 2007 and the increase in credit card
sales.
Net
inventories increased $1,390 (1%), to $147,398 as of June 30, 2007, from
$146,008 as of March 31, 2007. The increase in inventories is due to the
purchase of additional raw materials in June in order to fulfill a customer
order shipped in July and in preparation of producing additional Cryoport
Express® One-Way Shipper System units for market testing.
Net
fixed
assets decreased to $35,499 at June 30, 2007 from $38,400 at March 31, 2007
as a
result of depreciation in the amount of $5,756 offset by $2,805 for production
equipment purchases during the three months ended June 30, 2007.
Page
29
Intangible
assets decreased to $3,529 at June 30, 2007 from $4,696 at March 31, 2007
as a
result of amortization in the amount of $1,167 for the three months ended
June
30, 2007.
Deferred
financing costs decreased to $0 at June 30, 2007 compared to $4,699 at March
31,
2007 due to the expiration of the related convertible debentures and the
amortization of the remaining deferred financing fees during the three months
ended June 30, 2007.
Total
liabilities at June 30, 2007 were $2,673,600, a decrease of $97,919 (4%)
from
$2,771,519 as of March 31, 2007. Accounts payable was $292,988 at June 30,
2007,
a decrease of $13,694 (4%) from $306,682 at March 31, 2007. The accounts
payable
decrease is primarily due to the decreased accounting, consultant, and legal
fees payable resulting from the payments towards aged invoices which had
previously been delayed due to cash restrictions. This decrease was partially
offset by additional payables related to materials purchased during June
2007.
Accrued expenses increased $6,903 (7%) to $104,130 at June 30, 2007 from
$97,227
at March 31, 2007, resulting from the accrual of vendor invoices related
to
materials and services received in June. Accrued warranty costs increased
$375
to $55,782 at June 30, 2007 from $55,407 as of March 31, 2007 relating to
additional accrual for products shipped during the three months ended June
30,
2007. Accrued salaries were $155,687 at June 30, 2007, a decrease of $13,850
(8%) from $169,537 at March 31, 2007. This decrease is due to a partial payment
of Mr. Berry’s fiscal year 2007 bonus which had been approved by the board and
accrued in February 2007.
Per
the
terms of the convertible debenture agreements, the notes have a term of 180
days
from issuance and are redeemable by the Company with two days notice. The
notes
bear interest at 15% per annum and are convertible into shares of the Company’s
common stock at a ratio of 6.67 shares for every dollar of debt converted.
The
proceeds of the convertible notes have and will be used in the ongoing
operations of the Company. During the three months ended June 30, 2007 the
Company converted $98,500 of principal balances and $7,179 of accumulated
interest relating to these convertible debentures into 705,366 common stock
shares at a conversion price of $0.15 per share. As of June 30, 2007 the
remaining balance of the convertible debenture notes and accumulated interest
was $23,063.
Current
portion of related party notes payable increased $15,000 from $120,000 at
March
31, 2007 to $135,000 at June 30, 2007 due to the scheduled increase in the
monthly payment amounts on these notes in accordance with the terms of the
promissory notes, beginning October 1, 2006 and April 1, 2007 to total monthly
payments due of $5,000 and $7,500 respectively as specified in the terms
of the
notes. On July 31, 2007, the Company paid the April 1 note payments, due
on
these related party notes. Management expects to continue to pay all payments
due prior to the expiration of the 120-day grace periods.
Page
30
Current
portion of notes payable of $24,000 at June 30, 2007 had no change from March
31, 2007. Current portion of notes payable to officer increased from $45,000
as
of March 31, 2007 to $54,000 as of June 30, 2007 due to the scheduled increase
in monthly payments from $3,000 to $6,000 beginning in January
2008.
Long-term
related party notes payable decreased $9,981 to $1,613,860 at June 30, 2007
from
$1,623,841 at March 31, 2007 due to the transfer of additional $15,000 to
the
current portion in addition to aggregate payments made of $15,000 against
the
principal note balances which were offset by additional interest accrued
of
$20,019 for the three month period ended June 30, 2007.
Long-term
notes payable remained unchanged at $35,440 from March 31, 2007 to June 30,
2007. Notes payable to officer decreased $18,000 from $197,950 as of March
31,
2007 to $179,950 as of June 30, 2007 due to the $9,000 increase in the current
portion of the note and to the $9,000 paid against the principal balance
during
the three months ended June 30, 2007.
Liquidity
and Capital Resources
As
of
June 30, 2007, the Company’s current liabilities of $844,350 exceeded its
current assets of $743,603 by $100,747. Approximately 24% of current liabilities
represent accrued salaries and current portion of note payable to officer
for
executives who have opted to defer taking salaries until the Company has
achieved positive operating cash flows.
Total
cash increased $314,157 to $578,549 at June 30, 2007 from $264,392 at March
31,
2007 as a result of $630,140 of funds provided by financing activities mainly
due to proceeds from the issuance of common stock and exercise of warrants
partially offset by used in operating activities, partially offset by $313,178
of cash used in operating activities and $2,805 used for purchases of fixed
assets during the three months ended June 30, 2007.
Total
assets increased $298,893 to $782,580 as of June 30, 2007 compared to $483,687
as of March 31, 2007 mainly as a result of the increase in cash partially
offset
by decrease in accounts receivable.
The
Company’s total outstanding indebtedness decreased $97,919 to $2,673,600 at June
30, 2007 from $2,771,519 at March 31, 2007 primarily from the conversion
of
convertible notes payable to common stock, the decrease in accrued salaries
or
the payment of accrued bonus and the decrease in accounts payable related
to
payments of accrued consultant and legal fees.
The
Company does not expect to incur any material capital expenditures until
management is able to secure significant long-term funding for the launch
of the
new one-way product line or sales increase materially.
In
January 2007, the Company entered into an Agency Agreement with a broker
to
raise funds in a private placement offering of common stock under Regulation
D.
During the three months ended June 30, 2007, in connection with this agreement,
3,443,333 shares of the Company’s common stock were sold to investors at an
average price of $0.18 per share for proceeds of $554,140 to the Company,
net of
issuance costs of $67,860.
Page
31
Item
3. Controls and Procedures
As
of
June 30, 2007, an evaluation was carried out under the supervision and with
the
participation of the Company’s management, including our Chief Executive Officer
and our Chief Financial Officer, of the effectiveness of the design and
operation of our disclosure controls and procedures (as defined in Rule
13a-15(e) under the Securities Exchange Act of 1934). Based upon that
evaluation, the Chief Executive Officer and the Chief Financial Officer
concluded that the design and operation of these disclosure controls and
procedures were effective. No significant changes were made in our internal
controls or in other factors that could significantly affect these controls
subsequent to June 30, 2007.
(a)
Evaluation of Disclosure Controls and Procedures. The Company carried out
an
evaluation under the supervision and with the participation of the Company’s
management, including the Company’s Chief Executive Officer (“CEO”) and our
Chief Financial Officer (“CFO”), of the effectiveness of the Company’s
disclosure controls and procedures. Based upon that evaluation, the CEO and
CFO
concluded that as of June 30, 2007, our disclosure controls and procedures
were
effective in timely alerting them to the material information relating to
the
Company (or the Company’s consolidated subsidiaries) required to be included in
the Company’s periodic filings with the SEC, subject to the various limitation
on effectiveness set forth below under the heading , “LIMITATIONS ON THE
EFFECTIVENESS OF INTERNAL CONTROLS,” such that the information relating to the
Company, required to be disclosed in SEC reports (i) is recorded, processed,
summarized and reported within the time periods specified in SEC rules and
forms, and (ii) is accumulated and communicated to the Company’s management,
including our CEO and CFO, as appropriate to allow timely decisions regarding
required disclosure.
(b)
Changes in internal control over financial reporting. There has been no change
in the Company’s internal control over financial reporting that occurred during
the fiscal quarter ended June 30, 2007 that has materially affected, or is
reasonably likely to materially affect, the Company’s internal control over
financial reporting.
LIMITATIONS
ON THE EFFECTIVENESS OF INTERNAL CONTROLS
The
Company’s management, including the CEO and CFO, does not expect that our
disclosure controls and procedures on our internal control over financial
reporting will necessarily prevent all fraud and material error. An internal
control system, no matter now well conceived and operated, can provide only
reasonable, not absolute, assurance that the objectives of the control system
are met. Further, the design of the control system must reflect the fact
that
there are resource constraints, and the benefits of controls can provide
absolute assurance that all control issues and instances of fraud, if any,
within the Company have been detected. These inherent limitations include
the
realities that judgments in decision-making can be faulty, and that breakdowns
can occur because of simple error or mistake. Additionally, controls can
be
circumvented by the individual acts of some persons, by collusion of two
or more
people, or by management override of the internal control. The design of
any
system of controls also is based in part upon certain assumptions about the
likelihood of future events, and there can be no assurance that any design
will
succeed in achieving its stated goals under all potential future conditions.
Over time, control may become inadequate because of changes in conditions,
and/or the degree of compliance with the policies or procedures may
deteriorate.
Page
32
PART
II - OTHER INFORMATION
Item
1. Legal Proceedings
Inapplicable.
Item
2. Unregistered Sales of Equity Securities
During
the three month period ended June 30, 2007, 131,250 warrants were exercised
at
an average exercise price of $0.76 per share for cumulative proceeds of
$100,000.
In
January 2007, the Company entered into an Agency Agreement with a broker
to
raise funds in a private placement offering of common stock under Regulation
D.
During the three months ended June 30, 2007, in connection with this agreement,
3,443,333 shares of the Company’s common stock were sold to investors at an
average price of $0.18 per share for proceeds of $554,140 to the Company,
net of
issuance costs of $67,860.
In
October 2006, the Company entered into an Agency Agreement with a broker
to
raise capital in a private placement offering of convertible debentures under
Regulation D. From February 2006 through January 2007, the Company received
a
total of $120,000 under this private placement offering of convertible debenture
debt. Per
the
terms of the convertible debenture agreements, the notes have a term of 180
days
from issuance and are redeemable by the Company with two days notice. During
the
three months ended June 30, 2007 the Company converted $98,500 of principal
balances and $7,179 of accrued interest relating to these convertible debentures
into 705,366 common stock shares at a conversion price of $0.15 per share.
See
further information in Note 4 to the consolidated financial
statements.
In
April,
2007, the Company issued 375,000 shares of common stock in lieu of fees paid
to
a consultant. These shares were issued at a value of $1.02 per
share.
In
July
2007, the Company entered into an Agency Agreement with a broker to raise
funds
in a private placement offering of common stock under Regulation D. As of
August
10, 2007, in connection with this agreement, 168,750 shares of the Company’s
common stock were sold to investors at an average price of $0.80 per share
for
proceeds of $117,450 to the Company, net of issuance costs of
$17,550.
In
May
2007, the Company issued 154,331 shares of common stock pursuant to the terms
of
convertible debenture agreements. The Company converted $23,178 of convertible
notes with aggregate principal balances of $21,500 and accrued interest of
$1,678. The interest on the convertible notes was accrued at 15% per annum
through the conversion dates. The notes were converted into common stock
at a
ratio of 6.67 shares for every dollar of debt converted, representing
approximately $0.15 per share.
Page
33
In
July
2007, the Company issued a total of 699,438 warrants to purchase shares of
the
Company’s common stock at an average price of $0.29 per share to a broker in
connection with funds raised in private placement offerings.
On
July
2, 2007, the Company entered into a lease agreement with Viking Investors
-
Barents Sea, LLC for a building with approximately 11,881 square feet of
manufacturing and office space located at 20382 Barents Sea Circle, Lake
Forest,
CA, 92630. The lease agreement is for a period of two years with renewal
options
for three, one year periods, beginning September 1, 2007. The lease requires
initial monthly lease payments of $1.00 per square foot or $11,881 plus $0.23
per square foot or $2,733 per month for triple-net overhead building costs
equaling a total monthly payment of $14,614 during the first year of occupancy.
During the second year of occupancy, monthly per square foot lease payments
increase to $1.04 or $12,356. In connection with the lease agreement the
Company
issued 10,000 warrants to the lessor at an exercise price of $1.55 per share
for
a period of two years. The Company expects to move all operations to the
Lake
Forest facility by September 15, 2007.
Item
3. Defaults Upon Senior Securities
None
Item
4. Submission of Matters to a Vote of Security Holders
None
Item
5. Other Information
None
Page
34
Item
6. Exhibits
Exhibit
Index
10.4 |
Consultant
Agreement dated April 18, 2007 between CryoPort, Inc. and Malone
and
Associates, LLC
|
10.5 | Lease Agreement dated July 2, 2007 between CryoPort, Inc. and Viking Inventors - Barents Sea, LLC |
31.1 |
Rule
13a-14(a)/15d-14(a) Certification of Chief Executive
Officer
|
31.2 |
Rule
13a-14(a)/15d-14(a) Certification of Chief Financial
Officer
|
32.1 |
Certification
Pursuant to 18 U.S.C. §1350 of Chief Executive
Officer
|
32.2 |
Certification
Pursuant to 18 U.S.C. §1350 of Chief Financial
Officer
|
Page
35
SIGNATURES
In
accordance with the requirements of the Exchange Act, the Registrant caused
this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
CryoPort,
Inc.
|
||
|
|
|
Dated:
August 14, 2007
|
By: |
/s/
Peter Berry
|
|
||
PETER
BERRY, CEO, President
|
Dated:
August 14, 2007
|
By: |
/s/
Dee S. Kelly
|
|
||
DEE
S. KELLY, Vice President, Finance
|
Page
36